Higuchi, Tomoko
Ueno, Tomomi
Uchiyama, Shigeto
Matsuki, Shunji
Ogawa, Mariko
Takamatsu, Kiyoshi
Article History
Received: 22 November 2022
Accepted: 17 April 2023
First Online: 28 April 2023
Declarations
:
: This study was approved by the SOUSEIKAI Hakata Clinic Institutional Review Board (ethics code: H-101), and written informed consent was obtained from each participant. The trial was retrospectively registered at the University Hospital Medical Information Network center (ID: UMIN000047989, registration date: 10/06/2022). This study was conducted in compliance with the Declaration of Helsinki, ethical guidelines, and Act on the Protection of Personal Information.
: Not applicable.
: Tomoko Higuchi, Tomomi Ueno, and Shigeto Uchiyama are employees of Otsuka Pharmaceutical Co., Ltd. Shunji Matsuki declares no competing interests. Mariko Ogawa and Kiyoshi Takamatsu received lecture fees from Otsuka Pharmaceutical Co., Ltd.